Guangdong Taiantang Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 378.02 million compared to CNY 698.25 million a year ago. Revenue was CNY 378.02 million compared to CNY 698.25 million a year ago.

Net loss was CNY 253.68 million compared to CNY 145.34 million a year ago. Basic loss per share from continuing operations was CNY 0.33 compared to CNY 0.19 a year ago. Diluted loss per share from continuing operations was CNY 0.33 compared to CNY 0.19 a year ago.